8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Brain & Nervous System

Closed-loop neurostimulation via expression of magnetogenetics-sensitive protein in inhibitory neurons leads to reduction of seizure activity in a rat model of epilepsy

Bioeffects Seen

Authors not listed · 2023

Share:

Magnetic field stimulation of genetically modified brain cells successfully reduced seizure frequency and delayed onset in epileptic rats.

Plain English Summary

Summary written for general audiences

Researchers developed a new approach to control epileptic seizures using magnetic fields and genetically modified brain cells. Rats with modified inhibitory neurons showed significantly delayed seizure onset and fewer total seizures when exposed to magnetic field stimulation. This magnetogenetics technique could offer a targeted, on-demand treatment for drug-resistant epilepsy.

Why This Matters

This study represents a fascinating intersection of electromagnetic fields and medical treatment, demonstrating how magnetic fields can be harnessed therapeutically rather than simply studied for potential harm. The research shows that when brain cells are genetically modified to respond to magnetic fields, targeted stimulation can effectively suppress seizure activity. What makes this particularly relevant to EMF health discussions is that it validates the biological reality that electromagnetic fields can directly influence neural activity at the cellular level. While this study used intentional therapeutic exposure, it underscores the fundamental principle that our brains are indeed electromagnetically sensitive systems. The science demonstrates that magnetic fields, when properly applied, can produce measurable, beneficial changes in brain function through specific cellular pathways.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2023). Closed-loop neurostimulation via expression of magnetogenetics-sensitive protein in inhibitory neurons leads to reduction of seizure activity in a rat model of epilepsy.
Show BibTeX
@article{closed_loop_neurostimulation_via_expression_of_magnetogenetics_sensitive_protein_in_inhibitory_neurons_leads_to_reduction_of_seizure_activity_in_a_rat_model_of_epilepsy_ce4492,
  author = {Unknown},
  title = {Closed-loop neurostimulation via expression of magnetogenetics-sensitive protein in inhibitory neurons leads to reduction of seizure activity in a rat model of epilepsy},
  year = {2023},
  doi = {10.1016/j.brainres.2023.148591},
  
}
DOI: 10.1016/j.brainres.2023.148591PubMed: 37748572

Quick Questions About This Study

This study suggests magnetogenetics shows promise for epilepsy treatment. Rats with EPG-modified inhibitory neurons experienced delayed seizure onset and significantly fewer seizures compared to controls, indicating potential therapeutic applications for pharmacoresistant cases.
The genetically modified rats showed seizure onset at 1142 seconds compared to 644 seconds in controls, representing a 77% delay. This substantial difference suggests magnetic field activation of EPG proteins effectively suppresses seizure initiation.
Yes, rats with EPG-modified inhibitory interneurons experienced an average of 4.11 seizures compared to 8.33 in control rats, representing a 51% reduction in seizure frequency during the experimental period.
EPG encodes a protein that responds to magnetic fields, allowing researchers to control neural activity remotely. When expressed in specific brain cells, EPG enables magnetic field stimulation to activate or inhibit those neurons on demand.
The system detects seizure-related magnetic fields through magnetoencephalography, then automatically triggers magnetic stimulation of EPG-modified inhibitory neurons. This creates a feedback loop that suppresses seizure activity as it begins to develop.